Andrew M Davidoff

14PUBLICATIONS
109CO-AUTHORS
Haematological tumoursMolecular targetsInnate immunityTissue engineeringChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 17, 2025
RBM39 degrader invigorates innate immunity to eradicate neuroblastoma despite cancer cell plasticity.

Shivendra Singh, Jie Fang, Hongjian Jin

|Mar 28, 2024
Response of bilateral Wilms tumor to chemotherapy suggests histologic subtype and guides treatment.

Colton Duncan, Suraj Sarvode Mothi, Teresa C Santiago

Pageof 3